HER-2-Targeted T Cells May Have a Role in Ovarian Cancer Treatment

(PhysOrg.com) -- Ovarian cancer is the most lethal reproductive cancer for women, with just one-fifth of women diagnosed with advanced disease surviving five years. It is frequently reported that less than one-third of ovarian cancers overexpress the HER-2 protein, which is the molecular target of trastuzumab (Herceptin).

Read the whole article on Physorg

More from Physorg